Identification of low-molecular weight inhibitors of HIV-1 reverse transcriptase using a cell-based high-throughput screening system (original) (raw)
Synthesis, Biological Activity, and Crystal Structure of Potent Nonnucleoside Inhibitors of HIV-1 Reverse Transcriptase That Retain Activity against Mutant Forms of the Enzyme †
Kalyan Das
Journal of Medicinal Chemistry, 2007
View PDFchevron_right
Identification of novel bifunctional HIV-1 reverse transcriptase inhibitors
Deping Wang
Journal of Antimicrobial Chemotherapy, 2017
View PDFchevron_right
Identification of mechanistically distinct inhibitors of HIV-1 reverse transcriptase through fragment screening
Gilda Tachedjian
Proceedings of the National Academy of Sciences of the United States of America, 2015
View PDFchevron_right
Identification of benzofurano[3,2-d]pyrimidin-2-ones, a new series of HIV-1 nucleotide-competing reverse transcriptase inhibitors
Claudio Sturino
Bioorganic & Medicinal Chemistry Letters, 2013
View PDFchevron_right
Identification of the human immunodeficiency virus reverse transcriptase residues that contribute to the activity of diverse nonnucleoside inhibitors
Jon H Condra
Antimicrobial Agents and Chemotherapy, 1992
View PDFchevron_right
Slow, Tight-Binding HIV1 Reverse Transcriptase Non-Nucleoside Inhibitors Highly Active against Drug-Resistant Mutants
Gianluca SBARDELLA
Chemmedchem, 2007
View PDFchevron_right
Biological evaluation of inhibitors of reverse transcriptase from HIV type-1
T. Hadda
View PDFchevron_right
Discovery of 3-{5-[(6-Amino-1H-pyrazolo[3,4-b]pyridine-3-yl)methoxy]-2-chlorophenoxy}-5-chlorobenzonitrile (MK-4965): A Potent, Orally Bioavailable HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitor with Improved Potency against Key Mutant Viruses
Georgia McGaughey
Journal of Medicinal Chemistry, 2008
View PDFchevron_right
Design, Synthesis, and Antiviral Evaluation of Chimeric Inhibitors of HIV Reverse Transcriptase
Pinar Iyidogan, Kathleen Frey
ACS Medicinal Chemistry Letters, 2013
View PDFchevron_right
The PETT series, a new class of potent nonnucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase
T. Unge
Antimicrobial Agents and Chemotherapy, 1995
View PDFchevron_right
Novel HIV-1 non-nucleoside reverse transcriptase inhibitors: a patent review (2005 – 2010)
Peng Zhan
Expert Opinion on Therapeutic Patents, 2011
View PDFchevron_right
In-silico design and study of novel piperazinyl β-carbolines as inhibitor of HIV-1 reverse transcriptase
hardik Sharma
Medicinal Chemistry Research, 2014
View PDFchevron_right
Toward the Development of a Virus-Cell-Based Assay for the Discovery of Novel Compounds against Human Immunodeficiency Virus Type 1
Stuart Peltz
Antimicrobial Agents and Chemotherapy, 2003
View PDFchevron_right
Discovery of Non‐Nucleoside Inhibitors of HIV‐1 Reverse Transcriptase Competing with the Nucleotide Substrate
Marco Radi
Angewandte …, 2007
View PDFchevron_right
Screening of Potential HIV-1 Inhibitors/ Replication Blockers Using Secure Lentiviral in Vitro System
Alexander Ivanov
Acta Naturae, 2011
View PDFchevron_right
A High-Throughput Drug Screening System for HIV-1 Transcription Inhibitors
Olaf Kutsch
Journal of Biomolecular Screening, 2006
View PDFchevron_right
Synthesis and biological evaluation of (±)-benzhydrol derivatives as potent non-nucleoside HIV-1 reverse transcriptase inhibitors
Huifang Dai
Bioorganic & Medicinal Chemistry, 2011
View PDFchevron_right
Discovery of Wild-Type and Y181C Mutant Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors Using Virtual Screening with Multiple Protein Structures
Julian Tirado-rives
Journal of Chemical Information and Modeling, 2009
View PDFchevron_right
Novel HIV-1 reverse transcriptase inhibitors
Dirk Jochmans
Virus Research, 2008
View PDFchevron_right
Search for Non-Nucleoside Inhibitors of HIV-1 Reverse Transcriptase Using Chemical Similarity, Molecular Docking, and MM-GB/SA Scoring
Theresa Lyons, Ivan Tubert-brohman, Gabriela Barreiro
Journal of Chemical Information and Modeling, 2007
View PDFchevron_right
Taking aim at a moving target: designing drugs to inhibit drug-resistant HIV-1 reverse transcriptases
Stefan Sarafianos
Current opinion in structural biology, 2004
View PDFchevron_right
In silico screening of HIV-1 non-nucleoside reverse transcriptase and protease inhibitors
Carlos Alberto Montanari
European Journal of Medicinal Chemistry, 2008
View PDFchevron_right
Identification of a novel type of small molecule inhibitor against HIV-1
Kyung Lee Yu
BMB Reports, 2015
View PDFchevron_right
Kinetics of inhibition of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase by the novel HIV-1-specific nucleoside analogue [2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3'-spiro-5 "- (4"-amino-1",2"-oxathiole-2",2"-dioxide)thymine (TSAO-T)
Ana San Felix
The Journal of biological chemistry, 1992
View PDFchevron_right
De novo design and in-silico studies of novel 1-phenyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic acid derivatives as HIV-1 reverse transcriptase inhibitors
Subhash Saini
View PDFchevron_right
Bifunctional Inhibition of Human Immunodeficiency Virus Type 1 Reverse Transcriptase: Mechanism and Proof-of-Concept as a Novel Therapeutic Design Strategy
Ebrahim mohamed
Journal of Medicinal Chemistry, 2013
View PDFchevron_right
A nonnucleoside reverse transcriptase inhibitor active on human immunodeficiency virus type 1 isolates resistant to related inhibitors
Jon H Condra
Antimicrobial Agents and Chemotherapy, 1993
View PDFchevron_right